Results 141 to 150 of about 2,663,952 (341)

INTERACTIONS OF THE NERVOUS AND IMMUNE SYSTEMS IN HEALTH AND DISEASE

open access: hybrid, 2013
Е. А. Корнева   +1 more
openalex   +1 more source

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin   +2 more
wiley   +1 more source

NEW TECHNOLOGIES IN TREATMENT AND REHABILITATION OF DISEASES AND INJURIES OF THE NERVOUS SYSTEM

open access: hybrid, 2016
И. В. Литвиненко   +3 more
openalex   +2 more sources

Fibrinogen Changes Before and After Intravenous Thrombolysis as Predictors of Cerebral Injury and Clinical Outcomes in Acute Ischemic Stroke: A Multicenter Prospective Cohort Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Plasma fibrinogen is essential in thrombosis and fibrinolysis, yet its dynamic changes pre‐ and post‐intravenous thrombolysis (IVT) for predicting brain injury severity and prognosis in acute ischemic stroke (AIS) patients remain unclear.
Wenhai Zhai   +28 more
wiley   +1 more source

Preparation of Poly(MTZ)n–(DMAEMA)m Micelles and Study on Their Antibacterial Property

open access: yesACS Omega, 2020
Long Zhang   +7 more
doaj   +1 more source

Author Correction: The effect of biologically active compounds in the mucus of slugs Limax maximus and Arion rufus on human skin cells

open access: yesScientific Reports, 2021
Anna Leśków   +3 more
doaj   +1 more source

SARS-CoV-2 infection of the nervous system: A review of the literature on neurological involvement in novel coronavirus disease-(COVID-19)

open access: diamond, 2020
Alvin Oliver Payus   +4 more
openalex   +2 more sources

Exploratory Analysis of ELP1 Expression in Whole Blood From Patients With Familial Dysautonomia

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Familial dysautonomia (FD) is a hereditary neurodevelopmental disorder caused by aberrant splicing of the ELP1 gene, leading to a tissue‐specific reduction in ELP1 protein expression. Preclinical models indicate that increasing ELP1 levels can mitigate disease manifestations.
Alejandra González‐Duarte   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy